TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
0.7645
-0.0075 (-0.97%)
Aug 14, 2026, 11:18 AM EDT - Market open
TCRX's stock price has decreased by -57.06% in the past year and price targets may not have had time to catch up.
TScan Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 13, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $7 | Buy | Reiterates | $7 | +815.63% | Aug 12, 2026 |
| Needham | Needham | Buy Maintains $6 | Buy | Maintains | $6 | +684.83% | Aug 12, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $6 | Buy | Maintains | $6 | +684.83% | Jul 29, 2026 |
| Wedbush | Wedbush | Buy Maintains $5 | Buy | Maintains | $5 | +554.02% | Jun 23, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Jun 23, 2026 |